Inspira Technologies Oxy B.H.N. LTD IINN
We take great care to ensure that the data presented and summarized in this overview for Inspira Technologies OXY B.H.N. Ltd is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding IINN
View all-
Ieq Capital, LLC51.9KShares$113,7680.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il18.9KShares$41,2850.0% of portfolio
-
Cibc World Market Inc. Toronto, A615KShares$32,8500.0% of portfolio
-
Morgan Stanley New York, NY6.51KShares$14,2480.0% of portfolio
-
Bfsg, LLC650Shares$1,4230.0% of portfolio
-
Bank Of America Corp Charlotte, NC92Shares$2010.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
Latest Institutional Activity in IINN
Top Purchases
Top Sells
About IINN
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Insider Transactions at IINN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|